Brief: NGM Bio Reports Q3 2020 Financial Results

NGM Biopharmaceuticals

12/11/2020 21:16

Nov 12 (Reuters) - NGM Biopharmaceuticals Inc  NGM.O :
    * NGM BIO PROVIDES BUSINESS HIGHLIGHTS AND REPORTS THIRD
QUARTER
2020 FINANCIAL RESULTS
    * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.43
    * QTRLY RELATED PARTY REVENUE FROM COLLABORATION WITH MERCK
WAS
$23.5 MILLION VERSUS $21.6 MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.38, REVENUE VIEW $19.8
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4zMqDv 
Further company coverage:  NGM.O 

 ((Reuters.Briefs@thomsonreuters.com;))